Here are three key points:
1. The Congressional Budget Office estimated this tax suspension could save the companies about $5 billion.
2. The tax didn’t impact employment much, according to the Congressional Research Service. However, the report also concluded the tax didn’t seem necessary or beneficial.
3. Jason McGorman of Bloomberg Intelligence noted the tax suspension will help large medical device companies’ bottom lines.
More articles on devices:
Nanotherapeutics grants worldwide license to Amend Surgical for bone void filler: 5 notes
Moody’s: 3 important insights into the orthopedic device industry in 2016
MiMedx buys Stability Biologics — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
